Stem cell modeling of nervous system tumors
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050533 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Frank B Furnari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Diego, San Diego, CA 92037, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Nervous system tumors, particularly brain tumors, represent the most common tumors in children and one of the most lethal tumors in adults. Despite decades of research, there are few effective therapies for these cancers. Although human nervous system tumor cells and genetically engineered mouse models have served as excellent platforms for drug discovery and preclinical testing, they have limitations with respect to accurately recapitulating important aspects of the pathobiology of spontaneously arising human tumors. For this reason, attention has turned to the deployment of human stem cell engineering involving human embryonic or induced pluripotent stem cells, in which genetic alterations associated with nervous system cancers can be introduced. These stem cells can be used to create self-assembling three-dimensional cerebral organoids that preserve key features of the developing human brain. Moreover, stem cell-engineered lines are amenable to xenotransplantation into mice as a platform to investigate the tumor cell of origin, discover cancer evolutionary trajectories and identify therapeutic vulnerabilities. In this article, we review the current state of human stem cell models of nervous system tumors, discuss their advantages and disadvantages, and provide consensus recommendations for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Diego, San Diego, CA 92037, USA.
- Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Institute for Regenerative Medicine, School of Life Sciences and Technology, Tongji University, 200070 Shanghai, China.
- Department of Neurology, Weill Cornell Medicine, New York, NY 10065, USA.
- Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA.
- Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Frank B Furnari, Corina Anastasaki, Howard A Fine, Tomoyuki Koga, Lu Q Le, David H Gutmann
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Cancer Institute
- Fundamental Research Funds for the Central Universities of China
Zitieren
APA
Furnari, F. B., Anastasaki, C., Bian, S., Fine, H. A., Koga, T., Le, L. Q., Rodriguez, F. J., & Gutmann, D. H. (2024). Stem cell modeling of nervous system tumors. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050533
Vancouver
Furnari FB, Anastasaki C, Bian S, Fine HA, Koga T, Le LQ, et al. Stem cell modeling of nervous system tumors. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050533
BibTeX
@article{Furnari2024,
author = {Furnari, Frank B and Anastasaki, Corina and Bian, Shan and Fine, Howard A and Koga, Tomoyuki and Le, Lu Q and Rodriguez, Fausto J and Gutmann, David H},
title = {Stem cell modeling of nervous system tumors},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050533}
}
EUVIMED